How have NRC shares performed in 2023?

National Research's stock was trading at $37.30 on January 1st, 2023. Since then, NRC stock has increased by 11.0% and is now trading at $41.40. View the best growth stocks for 2023 here .

Are investors shorting National Research?

National Research saw a increase in short interest in November. As of November 15th, there was short interest totaling 126,900 shares, an increase of 31.9% from the October 31st total of 96,200 shares. Based on an average daily volume of 39,500 shares, the days-to-cover ratio is presently 3.2 days. Approximately 0.9% of the company's shares are sold short. View National Research's Short Interest .

When is National Research's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 13th 2024. View our NRC earnings forecast .

How were National Research's earnings last quarter?

National Research Co. (NASDAQ:NRC) announced its quarterly earnings data on Tuesday, November, 7th. The company reported $0.32 earnings per share for the quarter. The business had revenue of $37.95 million for the quarter. National Research had a trailing twelve-month return on equity of 40.74% and a net margin of 19.33%.

How often does National Research pay dividends? What is the dividend yield for National Research?

National Research announced a quarterly dividend on Friday, November 17th. Stockholders of record on Friday, December 29th will be given a dividend of $0.12 per share on Friday, January 12th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.16%. The ex-dividend date of this dividend is Thursday, December 28th. Read our dividend analysis for NRC .

Is National Research a good dividend stock?

National Research (NASDAQ:NRC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 1.15%. The dividend payout ratio is 41.38%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for NRC .

What ETF holds National Research's stock ?

Small Cap US Equity Select ETF holds 16,946 shares of NRC stock, representing 2.76% of its portfolio.

What is Michael D. Hays' approval rating as National Research's CEO?

85 employees have rated National Research Chief Executive Officer Michael D. Hays on Glassdoor.com . Michael D. Hays has an approval rating of 87% among the company's employees.

What other stocks do shareholders of National Research own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Research investors own include Altria Group (MO) , Enterprise Products Partners (EPD) , AbbVie (ABBV) , Dominion Energy (D) , Gilead Sciences (GILD) , Pfizer (PFE) , Toronto-Dominion Bank (TD) , Verizon Communications (VZ) , Wells Fargo & Company (WFC) and TD Ameritrade (AMTD) .

Who are National Research's major shareholders?

National Research's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (13.00%), Morgan Stanley (3.83%), Conestoga Capital Advisors LLC (3.15%), Northern Trust Corp (1.13%), Touchstone Capital Inc. (1.09%) and iA Global Asset Management Inc. (1.02%). Insiders that own company stock include Amandla Mk Trust, Joann M Martin, Jona S Raasch and Kevin R Karas. View institutional ownership trends .

How do I buy shares of National Research?

Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Does National Research have any subsidiaries?

The following companies are subsidiares of National Research: National Research Corporation Canada, PatientWisdom Inc., and The Governance Institute. Read More

National Research Stock Price, News & Analysis (NASDAQ:NRC)

$41.40

-0.10 (-0.24%)

(As of 11/28/2023 ET)

Compare

Today's Range: $41.24
▼
$41.60
50-Day Range: $40.51
▼
$46.78
52-Week Range: $36.61
▼
$47.60

Volume: 30,525 shs
Average Volume: 36,699 shs
Market Capitalization: $1.02 billion

P/E Ratio: 35.69
Dividend Yield: 1.16%
Price Target: N/A

National Research MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
0.88% of Float Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.19
Based on 7 Articles This Week
Insider Trading: Selling Shares
$117,651 Sold Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.56 out of 5 stars

Business Services Sector

267th out of 309 stocks

Commercial Physical Research Industry

13th out of 13 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for National Research.

3.0

Short Interest

Percentage of Shares Shorted
0.88% of the float of National Research has been sold short.
Short Interest Ratio / Days to Cover
National Research has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in National Research has recently increased by 31.91%, indicating that investor sentiment is decreasing significantly.

1.7

Dividend Strength

Dividend Yield
National Research pays a meaningful dividend of 1.15%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
National Research does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of National Research is 41.38%. This payout ratio is at a healthy, sustainable level, below 75%.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for NRC.

1.8

News and Social Media Coverage

News Sentiment
National Research has a news sentiment score of 0.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Business Services companies.
News Coverage This Week
MarketBeat has tracked 7 news articles for National Research this week, compared to 2 articles on an average week.
MarketBeat Follows
Only 1 people have added National Research to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, National Research insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $117,651.00 in company stock.
Percentage Held by Insiders
Only 2.00% of the stock of National Research is held by insiders.
Percentage Held by Institutions
47.26% of the stock of National Research is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of National Research is 35.69, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 121.28.
Price to Earnings Ratio vs. Sector
The P/E ratio of National Research is 35.69, which means that it is trading at a more expensive P/E ratio than the Business Services sector average P/E ratio of about 34.97.
Price to Book Value per Share Ratio
National Research has a P/B Ratio of 14.18. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About National Research Stock (NASDAQ:NRC)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

NRC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NRC Stock News Headlines

November 27, 2023 | au.news.yahoo.com

Russia prepares new lists of Ukrainian children for deportation, says NRC

November 26, 2023 | americanbankingnews.com

National Research (NASDAQ:NRC) Sees Unusually-High Trading Volume

November 28, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

November 24, 2023 | finance.yahoo.com

National Research (NASDAQ:NRC) Has Affirmed Its Dividend Of $0.12

November 20, 2023 | americanbankingnews.com

Insider Selling: National Research Co. (NASDAQ:NRC) Major Shareholder Sells $16,966.30 in Stock

November 19, 2023 | americanbankingnews.com

National Research (NASDAQ:NRC) Sees Strong Trading Volume

November 13, 2023 | news.yahoo.com

No signs of Russian retreat from occupied left bank in Kherson Oblast, reports NRC

November 9, 2023 | finance.yahoo.com

National Research Corporation (NASDAQ:NRC) Q3 2023 Earnings Call Transcript

November 28, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

November 7, 2023 | finance.yahoo.com

National Research Corporation Announces Third Quarter 2023 Results

November 6, 2023 | finance.yahoo.com

Should Weakness in National Research Corporation's (NASDAQ:NRC) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

November 5, 2023 | msn.com

Supermassive black holes are very messy eaters

November 4, 2023 | msn.com

Russians threaten to sack holders of Ukrainian citizenship from their jobs in occupied territories

October 24, 2023 | finance.yahoo.com

National Research Corporation to Broadcast its 2023 Third Quarter Conference Call Live on the Internet

October 23, 2023 | msn.com

Income contingent loan won't overburden PTPTN borrowers - Anwar

October 13, 2023 | msn.com

Nat'l Rehabilitation Commission, Civil Society Organizations Council Agree to Work Together

October 10, 2023 | msn.com

The end of the long dash: CBC stops broadcasting official time signal

October 10, 2023 | msn.com

Anti-Russian sentiment growing sharply in occupied Crimea - Resistance Center reveals reason

October 10, 2023 | ca.news.yahoo.com

The end of the long dash: CBC stops broadcasting official 1 p.m. time signal

October 9, 2023 | msn.com

Rehabilitation clinic for people with serious injuries and illnesses under way near Loughborough

October 5, 2023 | finance.yahoo.com

Katipult Receives Additional Support to Propel Digital Private Capital Network

October 4, 2023 | msn.com

'Phenomenal' national rehabilitation centre in Nottinghamshire set to become first of its kind

October 4, 2023 | msn.com

Pioneering facility to ‘transform how we provide clinical rehabilitation’ in UK

October 4, 2023 | ca.news.yahoo.com

U of A engineering student develops a device to help predict algae blooms

October 4, 2023 | proactiveinvestors.com

Hillcrest Energy secures government funding for electric vehicle inverter development program

September 26, 2023 | finance.yahoo.com

Lurie Children’s expands partnership with NRC Health to gain valuable consumer insights

September 21, 2023 | news.yahoo.com

Government approves £105m Stanford Hall NHS rehabilitation centre

See More Headlines

Receive NRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 9/22 Dividend: 9/15/2023
Dividend Payable: 9/22/2023
Last Earnings: 11/07/2023
Today: 11/28/2023
Ex-Dividend for 1/12 Dividend: 12/28/2023
Fiscal Year End: 12/31/2023
Dividend Payable: 1/12/2024
Next Earnings (Estimated): 2/13/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Commercial physical research
Sub-Industry: N/A
Sector: Business Services
Current Symbol: NASDAQ:NRC
CUSIP: N/A
CIK: 70487
Web: www.nrchealth.com
Phone: (402) 475-2525
Fax: 402-475-9061
Employees: 491
Year Founded: 1981

Profitability

EPS (Most Recent Fiscal Year): $1.16
Trailing P/E Ratio: 35.69
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $31.80 million
Net Margins: 19.33%
Pretax Margin: 25.53%
Return on Equity: 40.74%
Return on Assets: 22.18%

Debt

Debt-to-Equity Ratio: 0.24
Current Ratio: 0.61
Quick Ratio: 0.61

Sales & Book Value

Annual Sales: $151.57 million
Price / Sales: 6.71
Cash Flow: $1.50 per share
Price / Cash Flow: 27.59
Book Value: $2.92 per share
Price / Book: 14.18

Miscellaneous

Outstanding Shares: 24,560,000
Free Float: 23,969,000
Market Cap: $1.02 billion
Optionable: Not Optionable
Beta: 0.46

Social Links

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Mr. Michael D. Hays (Age 68)
Founder, CEO, President & Director
Comp: $131.65k
Mr. Kevin R. Karas CPA (Age 65)
Senior VP of Finance, CFO, Treasurer & Secretary
Comp: $292.81k
Ms. Jona S. Raasch (Age 64)
Chief Operating Officer
Comp: $308.01k
Ms. Helen L. Hrdy (Age 58)
Chief Growth Officer
Comp: $291.31k
Mr. Jon Boumstein
Chief Delivery Officer
Dr. Gregory Makoul M.S.
Ph.D., Chief Transformation Officer
Linda Stacy
Vice President of Finance
Megan Charko
Senior Manager of Content Marketing

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

NRC Stock Analysis - Frequently Asked Questions

How have NRC shares performed in 2023?: National Research's stock was trading at $37.30 on January 1st, 2023. Since then, NRC stock has increased by 11.0% and is now trading at $41.40.
View the best growth stocks for 2023 here.
Are investors shorting National Research?: National Research saw a increase in short interest in November. As of November 15th, there was short interest totaling 126,900 shares, an increase of 31.9% from the October 31st total of 96,200 shares. Based on an average daily volume of 39,500 shares, the days-to-cover ratio is presently 3.2 days. Approximately 0.9% of the company's shares are sold short.
View National Research's Short Interest.
When is National Research's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 13th 2024.
View our NRC earnings forecast.
How were National Research's earnings last quarter?: National Research Co. (NASDAQ:NRC) announced its quarterly earnings data on Tuesday, November, 7th. The company reported $0.32 earnings per share for the quarter. The business had revenue of $37.95 million for the quarter. National Research had a trailing twelve-month return on equity of 40.74% and a net margin of 19.33%.
How often does National Research pay dividends? What is the dividend yield for National Research?: National Research announced a quarterly dividend on Friday, November 17th. Stockholders of record on Friday, December 29th will be given a dividend of $0.12 per share on Friday, January 12th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.16%. The ex-dividend date of this dividend is Thursday, December 28th.
Read our dividend analysis for NRC.
Is National Research a good dividend stock?: National Research (NASDAQ:NRC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 1.15%. The dividend payout ratio is 41.38%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for NRC.

What ETF holds National Research's stock ?: Small Cap US Equity Select ETF holds 16,946 shares of NRC stock, representing 2.76% of its portfolio.
What is Michael D. Hays' approval rating as National Research's CEO?: 85 employees have rated National Research Chief Executive Officer Michael D. Hays on Glassdoor.com. Michael D. Hays has an approval rating of 87% among the company's employees.
What other stocks do shareholders of National Research own?: Based on aggregate information from My MarketBeat watchlists, some companies that other National Research investors own include Altria Group (MO), Enterprise Products Partners (EPD), AbbVie (ABBV), Dominion Energy (D), Gilead Sciences (GILD), Pfizer (PFE), Toronto-Dominion Bank (TD), Verizon Communications (VZ), Wells Fargo & Company (WFC) and TD Ameritrade (AMTD).
Who are National Research's major shareholders?: National Research's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (13.00%), Morgan Stanley (3.83%), Conestoga Capital Advisors LLC (3.15%), Northern Trust Corp (1.13%), Touchstone Capital Inc. (1.09%) and iA Global Asset Management Inc. (1.02%). Insiders that own company stock include Amandla Mk Trust, Joann M Martin, Jona S Raasch and Kevin R Karas.
View institutional ownership trends.
How do I buy shares of National Research?: Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
Does National Research have any subsidiaries?: The following companies are subsidiares of National Research: National Research Corporation Canada, PatientWisdom Inc., and The Governance Institute.
Read More

This page (NASDAQ:NRC) was last updated on 11/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial